普通肾内科医生在肾移植评估中的作用:2020核心课程
本文为《美国肾脏病杂志》肾脏病学核心课程综述,阐述肾移植是多数肾衰竭患者的首选替代治疗,美国每月新增逾3000例等待名单登记患者。文章介绍移植中心常规登记、评估、检测与候选者选择流程,并详细讨论心血管健康、衰弱、既往恶性肿瘤史和高体重指数等影响患者与移植物结局的因素,旨在促进普通与移植肾内科医生的沟通。
要点
- 肾移植是多数肾衰竭患者的首选替代治疗方式
- 普通肾内科医生负责向移植中心转诊并启动候选者评估
- 心血管健康、衰弱、肿瘤史与高BMI是评估中需重点权衡的因素
核心结论
- 肾移植是多数肾衰竭患者首选的替代治疗,普通肾内科医生在转诊与评估中起关键作用。
- 理解移植中心的登记、评估与候选者选择标准有助于改善普通与移植肾内科医生之间的沟通。
研究设计与样本
- 《美国肾脏病杂志》肾脏病学核心课程(Core Curriculum 2020)综述。
- 围绕肾移植候选者评估中影响患者与移植物结局的因素及移植中心常用标准进行阐述。
主要发现
- 美国每月有超过3000例新患者登记进入肾移植等待名单。
- 候选者评估通常由普通肾内科医生转诊至移植中心开始。
- 心血管健康、作为生物学年龄指标的衰弱、既往恶性肿瘤史和高体重指数是多数候选者共有的评估问题。
临床怎么用
- 普通肾内科医生应尽早为合适患者启动移植中心转诊。
- 评估时系统关注心血管健康、衰弱、肿瘤史与体重指数等影响移植结局的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transplantation is the preferred modality of replacement therapy for most patients with kidney failure. In the United States, more than 3,000 new patients are registered each month on the kidney transplant waiting list for this life-saving therapy. A potential kidney transplant recipient's evaluation typically begins with a referral by the general nephrologist to a transplantation center. In this installment in the Core Curriculum in Nephrology, we endeavor to achieve a shared understanding of the patient factors that contribute to optimal patient and allograft outcomes following kidney transplantation. In addition, we provide a primer on the routine listing, evaluation, testing, and candidate selection process in an effort to demystify the current criteria commonly used by transplantation centers. Issues common to a majority of candidates, including cardiovascular health, frailty as a measure of biological age, history of prior malignancy, and high body mass index are reviewed in detail. With this knowledge, we hope to facilitate improved communication between general and transplantation nephrologists.
引用
- Virmani S, Asch WS. The Role of the General Nephrologist in Evaluating Patients for Kidney Transplantation: Core Curriculum 2020. Am J Kidney Dis. 2020. PMID: 32199707. doi:10.1053/j.ajkd.2020.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。